U.S. flag

An official website of the United States government

NM_001128159.3(VPS53):c.1704+1G>A AND Pontoneocerebellar hypoplasia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Feb 24, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003155873.1

Allele description [Variation Report for NM_001128159.3(VPS53):c.1704+1G>A]

NM_001128159.3(VPS53):c.1704+1G>A

Genes:
LOC126862456:CDK7 strongly-dependent group 2 enhancer GRCh37_chr17:463241-464440 [Gene]
VPS53:VPS53 subunit of GARP complex [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.3
Genomic location:
Preferred name:
NM_001128159.3(VPS53):c.1704+1G>A
HGVS:
  • NC_000017.11:g.560425C>T
  • NG_034190.1:g.159432G>A
  • NG_086954.1:g.525C>T
  • NM_001128159.3:c.1704+1G>AMANE SELECT
  • NM_001366253.2:c.1704+1G>A
  • NM_001366254.2:c.1110+1G>A
  • NM_018289.4:c.1617+1G>A
  • NC_000017.10:g.463665C>T
  • NM_001128159.2:c.1704+1G>A
Molecular consequence:
  • NM_001128159.3:c.1704+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001366253.2:c.1704+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001366254.2:c.1110+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_018289.4:c.1617+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Pontoneocerebellar hypoplasia
Synonyms:
Pontocerebellar hypoplasia; Non-syndromic pontocerebellar hypoplasia
Identifiers:
MONDO: MONDO:0020135; MedGen: C1261175; Orphanet: 98523; OMIM: PS607596

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003845164Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely pathogenic
(Feb 24, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV003845164.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: VPS53 c.1704+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 248988 control chromosomes. To our knowledge, no occurrence of c.1704+1G>A in individuals affected with Pontocerebellar Hypoplasia, Type 2E and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 10, 2023